Page last updated: 2024-08-26

imipenem, anhydrous and Appendicitis

imipenem, anhydrous has been researched along with Appendicitis in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's6 (46.15)18.2507
2000's5 (38.46)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badal, RE; Hackel, MA; Lob, SH; Sahm, DF1
Gnagy, FT; Haragan, AF; Mileski, JP; Mileski, WJ; Parcells, JP1
Babinchak, T; Campos, M; Ellis-Grosse, EJ; Loh, E; Oliva, ME; Pasternak, J; Rekha, A; Rose, GM; Yellin, A1
Mallick, R; Schell, SR; Sun, S1
Johnson, SB; Orrico, RP; Suding, PN; Wilson, SE1
Akamo, Y; Manabe, T; Mizokami, M; Mizuno, I; Mohri, N; Shinagawa, N; Takeyama, H; Yuasa, H1
Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY1
Faulkner, K; Wilson, SE1
Allo, MD; Bennion, RS; Finegold, SM; Kathir, K; Lentz, M; Meute, M; Thompson, JE1
Ahmed, TM; Salim, AS1
Heikkinen, E; Seppänen, J; Uhari, M1
Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Yellin, AE1
Appleman, MD; Berne, TV; Chenella, FC; Gill, MA; Heseltine, PN; Leedom, JM; Yellin, AE1

Trials

8 trial(s) available for imipenem, anhydrous and Appendicitis

ArticleYear
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
    BMC infectious diseases, 2005, Oct-19, Volume: 5

    Topics: Abdomen; Adult; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Cholecystitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Diverticulitis; Double-Blind Method; Drug Combinations; Female; Humans; Imipenem; Intestinal Perforation; Male; Middle Aged; Minocycline; Peptic Ulcer Perforation; Peritonitis; Tigecycline

2005
Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin.
    Surgical infections, 2007, Volume: 8, Issue:2

    Topics: Abdominal Abscess; Aged; Anti-Bacterial Agents; APACHE; Appendicitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials, Phase III as Topic; Digestive System Surgical Procedures; Double-Blind Method; Drug Combinations; Female; Health Resources; Humans; Imipenem; Length of Stay; Male; Middle Aged; Minocycline; Postoperative Complications; Reoperation; Risk Factors; Tigecycline

2007
Concordance of interrater assessments of surgical methods to achieve source control of intra-abdominal infections.
    American journal of surgery, 2008, Volume: 196, Issue:1

    Topics: Abdominal Abscess; Abdominal Cavity; Aged; Anti-Bacterial Agents; Appendicitis; Cholecystitis; Decision Making; Digestive System Diseases; Diverticulitis; Double-Blind Method; Female; Humans; Imipenem; Intestinal Perforation; Male; Middle Aged; Minocycline; Peritonitis; Professional Practice; Tigecycline

2008
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
    Archives of surgery (Chicago, Ill. : 1960), 1997, Volume: 132, Issue:12

    Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome

1997
Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
    The American surgeon, 1998, Volume: 64, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Bacteriological Techniques; Cause of Death; Cilastatin; Clindamycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Risk Factors; Survival Rate; Thienamycins; Tobramycin; Treatment Outcome

1998
Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis.
    The American surgeon, 1999, Volume: 65, Issue:2

    Topics: Adolescent; Adult; Aged; Appendicitis; Appendix; Child; Cilastatin; Cilastatin, Imipenem Drug Combination; Clavulanic Acids; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gangrene; Humans; Imipenem; Intestinal Perforation; Male; Middle Aged; Prospective Studies; Ticarcillin; Treatment Outcome

1999
Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    The Pediatric infectious disease journal, 1992, Volume: 11, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Metronidazole; Tobramycin

1992
Intramuscular imipenem as adjuvant therapy for acute cholecystitis and perforated or gangrenous appendicitis.
    Chemotherapy, 1991, Volume: 37 Suppl 2

    Topics: Adult; Appendicitis; Cholecystitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Combined Modality Therapy; Drug Combinations; Female; Gangrene; Half-Life; Humans; Imipenem; Injections, Intramuscular; Intestinal Perforation; Lidocaine; Male; Prospective Studies; Rupture, Spontaneous

1991

Other Studies

5 other study(ies) available for imipenem, anhydrous and Appendicitis

ArticleYear
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.
    Journal of the Pediatric Infectious Diseases Society, 2017, Mar-01, Volume: 6, Issue:1

    Topics: Adolescent; Amikacin; Appendicitis; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Europe; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests

2017
Using antimicrobial solution for irrigation in appendicitis to lower surgical site infection rates.
    American journal of surgery, 2009, Volume: 198, Issue:6

    Topics: Abdominal Abscess; Adult; Antibiotic Prophylaxis; Appendicitis; Drug Combinations; Humans; Imipenem; Intraoperative Care; Retrospective Studies; Sodium Bicarbonate; Sodium Chloride; Sodium Hypochlorite; Surgical Wound Infection; Therapeutic Irrigation

2009
Perforated acute appendicitis in a patient with AIDS/HIV infection: report of a case.
    Surgery today, 1995, Volume: 25, Issue:1

    Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Appendectomy; Appendicitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Fever of Unknown Origin; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunization, Passive; Intestinal Perforation; Male; Postoperative Complications; Rupture, Spontaneous

1995
Antibiotic treatment of acute appendicitis - initial observations.
    Saudi medical journal, 2001, Volume: 22, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Appendicitis; Child; Diagnosis, Differential; Female; Humans; Imipenem; Male; Middle Aged; Pilot Projects; Saudi Arabia; Treatment Outcome

2001
Imipenem therapy for perforated and gangrenous appendicitis.
    Surgery, gynecology & obstetrics, 1986, Volume: 162, Issue:1

    Topics: Adult; Aged; Appendectomy; Appendicitis; Ascitic Fluid; Cilastatin; Clindamycin; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Gangrene; Gentamicins; Humans; Imipenem; Intestinal Perforation; Length of Stay; Middle Aged; Rupture, Spontaneous; Thienamycins

1986